340 related articles for article (PubMed ID: 25891319)
21. Consensus guidelines on the neurologist's role in the management of neurogenic lower urinary tract dysfunction in multiple sclerosis.
De Ridder D; Van Der Aa F; Debruyne J; D'hooghe MB; Dubois B; Guillaume D; Heerings M; Ilsbroukx S; Medaer R; Nagels G; Seeldrayers P; Van Landegem W; Willekens B; Zicot AF
Clin Neurol Neurosurg; 2013 Oct; 115(10):2033-40. PubMed ID: 23880016
[TBL] [Abstract][Full Text] [Related]
22. Consensus document on the multidisciplinary management of neurogenic lower urinary tract dysfunction in patients with multiple sclerosis.
Medina-Polo J; Adot JM; Allué M; Arlandis S; Blasco P; Casanova B; Matías-Guiu J; Madurga B; Meza-Murillo ER; Müller-Arteaga C; Rodríguez-Acevedo B; Vara J; Zubiaur MC; López-Fando L
Neurourol Urodyn; 2020 Feb; 39(2):762-770. PubMed ID: 31943361
[TBL] [Abstract][Full Text] [Related]
23. Sacral neuromodulation for the treatment of neurogenic lower urinary tract dysfunction caused by multiple sclerosis: a single-centre prospective series.
Engeler DS; Meyer D; Abt D; Müller S; Schmid HP
BMC Urol; 2015 Oct; 15():105. PubMed ID: 26498275
[TBL] [Abstract][Full Text] [Related]
24. Early urological care of patients with spinal cord injury.
Welk B; Schneider MP; Thavaseelan J; Traini LR; Curt A; Kessler TM
World J Urol; 2018 Oct; 36(10):1537-1544. PubMed ID: 29948046
[TBL] [Abstract][Full Text] [Related]
25. Intravesical vanilloids for treating neurogenic lower urinary tract dysfunction in patients with multiple sclerosis: A systematic review and meta-analysis. A report from the Neuro-Urology Promotion Committee of the International Continence Society (ICS).
Phé V; Schneider MP; Peyronnet B; Abo Youssef N; Mordasini L; Chartier-Kastler E; Bachmann LM; Kessler TM
Neurourol Urodyn; 2018 Jan; 37(1):67-82. PubMed ID: 28618110
[TBL] [Abstract][Full Text] [Related]
26. [Urinary tract dysfunction in spinal cord injury patients].
Moslavac S; Dzidić I; Moslavac A; Vlahek P; Filipan Z
Lijec Vjesn; 2014; 136(5-6):147-52. PubMed ID: 25154184
[TBL] [Abstract][Full Text] [Related]
27. Follow-up for the upper urinary tract in patients with high-risk neurogenic lower urinary tract dysfunction.
Sinha S
World J Urol; 2023 Nov; 41(11):3309-3316. PubMed ID: 37702753
[TBL] [Abstract][Full Text] [Related]
28. The urological management of children with spinal cord injury.
Eswara JR; Castellan M; González R; Mendieta N; Cendron M
World J Urol; 2018 Oct; 36(10):1593-1601. PubMed ID: 30105455
[TBL] [Abstract][Full Text] [Related]
29. The AUA/SUFU Guideline on Adult Neurogenic Lower Urinary Tract Dysfunction: Treatment and Follow-up.
Ginsberg DA; Boone TB; Cameron AP; Gousse A; Kaufman MR; Keays E; Kennelly MJ; Lemack GE; Rovner ES; Souter LH; Yang CC; Kraus SR
J Urol; 2021 Nov; 206(5):1106-1113. PubMed ID: 34495688
[TBL] [Abstract][Full Text] [Related]
30. A Primary Care Provider's Guide to Management of Neurogenic Lower Urinary Tract Dysfunction and Urinary Tract Infection After Spinal Cord Injury.
Milligan J; Goetz LL; Kennelly MJ
Top Spinal Cord Inj Rehabil; 2020; 26(2):108-115. PubMed ID: 32760189
[TBL] [Abstract][Full Text] [Related]
31. Cannabinoids for treating neurogenic lower urinary tract dysfunction in patients with multiple sclerosis: a systematic review and meta-analysis.
Abo Youssef N; Schneider MP; Mordasini L; Ineichen BV; Bachmann LM; Chartier-Kastler E; Panicker JN; Kessler TM
BJU Int; 2017 Apr; 119(4):515-521. PubMed ID: 28058780
[TBL] [Abstract][Full Text] [Related]
32. [Neurogenic urinary bladder in patients with spinal cord injury. Protocol of surveillance and management].
Hadiji N; Miri I; Ben Salah FZ; Rahali H; Koubaa S; Lebib S; Dziri C
Tunis Med; 2009 Feb; 87(2):137-43. PubMed ID: 19522448
[TBL] [Abstract][Full Text] [Related]
33. Management goals for the spina bifida neurogenic bladder: a review from infancy to adulthood.
Mourtzinos A; Stoffel JT
Urol Clin North Am; 2010 Nov; 37(4):527-35. PubMed ID: 20955904
[TBL] [Abstract][Full Text] [Related]
34. Outcomes of electrical stimulation of the neurogenic bladder: results of a two-year follow-up study.
Radziszewski K
NeuroRehabilitation; 2013; 32(4):867-73. PubMed ID: 23867413
[TBL] [Abstract][Full Text] [Related]
35. Outcome of Different Approaches to Reduce Urinary Tract Infection in Patients With Spinal Cord Lesions: A Systematic Review.
Chang SC; Zeng S; Tsai SJ
Am J Phys Med Rehabil; 2020 Nov; 99(11):1056-1066. PubMed ID: 32149818
[TBL] [Abstract][Full Text] [Related]
36. Management of spinal cord injury patients with neurogenic lower urinary tract dysfunction using minimally invasive and surgical therapies in Taiwan.
Chen SF; Kuo HC
Int Urol Nephrol; 2024 Apr; 56(4):1205-1216. PubMed ID: 38036803
[TBL] [Abstract][Full Text] [Related]
37. The treatment of lower urinary tract symptoms in patients with multiple sclerosis: a systematic review.
Tubaro A; Puccini F; De Nunzio C; Digesu GA; Elneil S; Gobbi C; Khullar V
Curr Urol Rep; 2012 Oct; 13(5):335-42. PubMed ID: 22886612
[TBL] [Abstract][Full Text] [Related]
38. Surveillance Strategies for Neurogenic Lower Urinary Tract Dysfunction.
Vince RA; Klausner AP
Urol Clin North Am; 2017 Aug; 44(3):367-375. PubMed ID: 28716318
[TBL] [Abstract][Full Text] [Related]
39. Assessment of the introduction of an adolescent transition urology clinic using a validated questionnaire.
Shalaby MS; Gibson A; Granitsiotis P; Conn G; Cascio S
J Pediatr Urol; 2015 Apr; 11(2):89.e1-5. PubMed ID: 25797859
[TBL] [Abstract][Full Text] [Related]
40. The current management of the neurogenic bladder in children with spina bifida.
Frimberger D; Cheng E; Kropp BP
Pediatr Clin North Am; 2012 Aug; 59(4):757-67. PubMed ID: 22857827
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
